
Figure 1.
A transmission electron microscope (TEM) image that depicts selenium nanoparticles (SeNPs). The image showcases the nanoparticles' nearly spherical shape, smooth surface, and uniform size distribution (from 32.1 to 66.7 nm)
Table 1.
Ingredients and chemical analysis of basal diets (on air-dry weight basis)
| Ingredients | % |
|---|---|
| Fish meal | 18 |
| Soybean meal 44% | 17 |
| Wheat bran | 26.2 |
| Maize | 24.2 |
| Corn gluten meal 60% | 10 |
| Wheat meal | 2.1 |
| Vegetable oil | 1 |
| Fish oil | 1 |
| Vitamin premix1 | 0.25 |
| Mineral premix2 | 0.25 |
| Total | 100 |
| Proximate chemical composition | |
| Crude protein (N×6.25) | 31.23 |
| Crude lipids | 8.49 |
| Ash | 4.89 |
| Crude fiber | 4.92 |
| Nitrogen free extract (NFE)3 | 50.47 |
| Gross energy (GE, MJ/Kg diet)4 | 18.39 |
1 Composition of mineral premix kg−1: manganese, 53 g; zinc, 40 g; iron, 20 g; copper, 2.7 g; iodine, 0.34 g; selenium, 70 mg; cobalt, 70 mg and calcium carbonate as carrier up to 1 kg.
Table 2.
Growth performance and feed efficiency of Nile tilapia fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum ) (1, 2 and 3 g kg−1) or bacterial synthesized selenium nanoparticles (SeNPs) (1, 2 and 3 mg kg−1) for 26 days and then exposed to sublethal dose of acrylamide (
96 h LC50= 34.6 mg L−1) for 30 days
| IBW (g) | FBW (g) | WG (g) | DWG (g) | DWG (%) | TFI (g) | FCR (g/g) | RGR (g/g) | SGR (% d−1) | |
|---|---|---|---|---|---|---|---|---|---|
| CTR | 24.25±0.03 a | 71.8±0.25 ab | 47.55±0.37 ab | 0.84±0.04 ab | 84.91±0.13 ab | 33.65±0.31 b | 1.41±0.1 ab | 66.15±0.11 | 1.93±0.16 ab |
| PM1 | 23.85±0.03 b | 64.2±0.11 b | 40.35±0.12 a | 0.72±0.73 a | 72.05±0.42 a | 35.10±0.0 1 ab | 1.14±0.12 b | 62.54±0.40 | 1.76±0.11 b |
| PM2 | 23.75±0.09 b | 71.73±0.96 ab | 47.98±0.83 ab | 0.85±0.32 ab | 85.68±0.33 ab | 35.10±0.01 ab | 1.46±0.1 ab | 66.84±0.81 | 1.97±0.04 ab |
| PM3 | 23.6±0.06 b | 71.33±0.86 ab | 47.73±0.93 ab | 0.85±0.10 ab | 85.24±0.60 ab | 35.15±0.03 ab | 1.45±0.2 ab | 66.44±2.9 | 1.96±0.2 ab |
| SeNPs1 | 23.83±0.14 b | 88.73±0.84 ab | 64.90±0.91 a | 1.15±0.03 a | 115.89±0.42 a | 36.65±0.83 a | 1.87±0.04 a | 73.11±0.64 | 2.34±0.04 a |
| SeNPs2 | 23.85±0.03 b | 87.2±0.83 a | 63.35±0.81 a | 1.13±0.06 a | 113.13±0.82 a | 35.10±0.01 ab | 1.80±0.10 a | 72.54±0.21 | 2.31±0.18 a |
| SeNPs3 | 23.8±0.06 b | 70.0±0.91 ab | 46.20±0.98 ab | 0.82±0.14 ab | 82.50±0.14 ab | 35.10±0.01 ab | 1.31±0.22 ab | 65.10±0.01 | 1.90±0.20 ab |
| P value | |||||||||
| linear | 0.700 | 0.007 | 0.006 | 0.006 | 0.006 | 0.004 | 0.013 | 0.020 | 0.010 |
| quadratic | 0.100 | 0.504 | 0.555 | 0.555 | 0.555 | 0.001 | 0.301 | 0.702 | 0.684 |
| cubic | 0.300 | 0.513 | 0.537 | 0.537 | 0.537 | 0.906 | 0.555 | 0.657 | 0.620 |
[ii] PM1, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum ) 1 mg kg−1;
[iii] PM2, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum ) 2 mg kg−1;
[iv] PM3, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum ) 3 mg kg−1;
[v] SeNPs1, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.001 mg kg−1;
[vi] SeNPs2, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.002 mg kg−1;
[vii] SeNPs3, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.003 mg kg−1.
Table 3.
Blood biochemical profile of Nile tilapia fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) (1, 2 and 3 g kg−1) or selenium nanoparticles (SeNPs) (1, 2 and 3 mg kg−1) for 26 days and then exposed to sublethal dose of acrylamide (
96 h LC50 = 34.6 mg L−1) for 30 days
| Treatments | Parameters | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| TP (g dL−1) | ALB (g dL−1) | GLOB (g dL−1) | A/G (%) | CR (mg dL−1) | UA (mg dL−1) | AST (UL) | ALT (UL) | T.G (mg dL−1) | |
| CTR | 6.08±0.19 ab | 3.68±0.58 ab | 2.40±0.29 | 1.64±0.45 | 0.53±0.03 a | 1.69±0.13 a | 211.80±0.61 a | 24.5±0.81 a | 182.28±0.91 a |
| PM1 | 7.09±0.39 a | 4.04±0.29 a | 3.05±0.01 | 1.32±0.44 | 0.33±0.03 b | 1.36±0.33 b | 55.64±0.31 e | 18.04±0.21 b | 98.56±0.29 e |
| PM2 | 6.51±0.09 ab | 3.91±0.11 ab | 2.60±0.19 | 1.54±0.14 | 0.24±0.01 c | 1.05±0.61 d | 102.30±0.58 b | 25.05±0.73 a | 162.2±0.99 b |
| PM3 | 5.61±0.29 b | 2.91±0.21 b | 2.70±0.29 | 1.10±0.12 | 0.19±0.01 cd | 0.95±0.11 e | 43.34±0.21 f | 13.25±0.58 c | 163.7±0.01 b |
| SeNPs1 | 6.75±0.28 ab | 3.64±0.31 ab | 3.11±0.39 | 1.19±0.11 | 0.12±0.01 e | 0.52±0.21 g | 28.29±0.58 g | 10.25±0.01 d | 148.5±0.47 c |
| SeNPs2 | 6.32±0.25 ab | 3.71±0.01 ab | 2.61±0.59 | 1.45±0.26 | 0.16±0.01 de | 0.68±0.01 f | 77.27±0.51 d | 18.11±0.22 b | 146.7±0.33 c |
| SeNPs3 | 5.41±0.39 b | 3.03±0.14 b | 2.40±0.09 | 1.29±0.16 | 0.32±0.01 b | 1.24±0.31 c | 82.24±0.41 c | 13.54±0.25 c | 140.11±0.28 d |
| P value | |||||||||
| linear | 0.048 | 0.039 | 0.797 | 0.334 | <0.001 | <0.001 | <0.001 | <0.001 | 0.526 |
| quadratic | 0.093 | 0.713 | 0.131 | 0.313 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| cubic | 0.846 | 0.908 | 0.916 | 0.807 | 0.053 | <0.001 | <0.001 | 0.230 | <0.001 |
[i] PM1, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum ) 1 mg kg−1;
[ii] PM2, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum ) 2 mg kg−1;
[iii] PM3, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum ) 3 mg kg−1;
[iv] SeNPs1, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.001 mg kg−1;
[v] SeNPs2, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.002 mg kg−1;
[vi] SeNPs3, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.003 mg kg−1.
Table 4.
Immune parameters of Nile tilapia fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) (1, 2 and 3 g kg−1) or selenium nanoparticles (SeNPs) (1, 2 and 3 mg kg−1) for 26 days and then exposed to sublethal dose of acrylamide (
96 h LC50 = 34.6 mg L−1) for 30 days
| Treatments | Parameters | |||||
|---|---|---|---|---|---|---|
| IGA (ng ml−1) | IGM (ng ml−1) | AChE (pg ml−1) | C3 (mg dL−1) | LZM (ng ml−1) | IL-1β (pg ml−1) | |
| CTR | 1045.90±0.34 a | 775.35±0.89 a | 687.52±0.99 b | 38.34±0.99 b | 0.81 ±0.01 f | 827.54 ±0.28 b |
| PM1 | 522.25±0.73 c | 223.14±0.44 g | 583.18±0.02 c | 33.50±0.15 c | 1.58±0.03 d | 630.02 ±0.97 d |
| PM2 | 411.14±0.21 d | 720.11±0.91 b | 291.19±0.95 e | 18.58±0.11 e | 0.66±0.33 g | 1005.37±0.51 a |
| PM3 | 355.25±0.11 e | 343.34±0.84 e | 895.25±0.61 a | 52.25±0.01 a | 4.24±0.41 a | 286.68±0.22 g |
| SeNPs1 | 168.86±0.10 g | 281.11±0.31 f | 650.50±0.89 b | 39.39 ±0.81 b | 3.55±0.28 b | 757.64±0.27 c |
| SeNPs2 | 282.28±0.41 f | 530.25±0.51 c | 525.25±0.91 c | 31.13 ±0.71 c | 2.71±0.46 c | 535.35±0.41 e |
| SeNPs3 | 653.35±0.51 b | 445.25±0.64 d | 470.11±0.79 d | 25.25 ±0.01 d | 0.99±0.75 e | 464.28±0.61 f |
| P value | ||||||
| linear | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| quadratic | <0.001 | <0.001 | 0.892 | 0.012 | 0.175 | 0.780 |
| cubic | 0.014 | <0.001 | 0.007 | 0.470 | <0.001 | 0.358 |
[i] PM1, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum ) 1 mg kg−1;
[ii] PM2, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum ) 2 mg kg−1;
[iii] PM3, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum ) 3 mg kg−1;
[iv] SeNPs1, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.001 mg kg−1;
[v] SeNPs2, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.002 mg kg−1;
[vi] SeNPs3, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.003 mg kg−1.
Table 5.
Antioxidant activities of Nile tilapia fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) (1, 2 and 3 g kg−1) or selenium nanoparticles (SeNPs) (1, 2 and 3 mg kg−1) for 26 days and then exposed to sublethal dose of acrylamide (
96 h LC50 = 34.6 mg L−1) for 30 days
| SOD (U mL−1) | GSH (ng mL−1) | TAC (ng mL−1) | MDA (nmol mL−1) | |
|---|---|---|---|---|
| CTR | 44.68±1.99 f | 61.25±0.56 f | 0.79±0.16 f | 3.85±0.39 b |
| PM1 | 99.75±0.39 d | 116.24±0.39 d | 1.29±0.03 d | 2.20±0.03 d |
| PM2 | 28.53±0.51 g | 38.52±0.36 g | 0.58 ±0.96 g | 4.52±0.91 a |
| PM3 | 180.25±0.63 a | 220.21±0.64 a | 3.54 ±0.52 a | 0.85±0.35 e |
| SeNPs1 | 82.28±0.78 e | 95.59±0.24 e | 0.91±0.54 e | 2.82±0.43 c |
| SeNPs2 | 121.15±0.77 c | 134.34±0.63 c | 2.16 ±0.21 c | 1.82±0.11 d |
| SeNPs3 | 149.67±0.41 b | 152.36±0.75 b | 2.67±0.23 b | 1.16±0.01 e |
| P value | ||||
| linear | ˂0.001 | ˂0.001 | ˂0.001 | ˂0.001 |
| quadratic | ˂0.001 | ˂0.001 | ˂0.001 | 0.695 |
| cubic | ˂0.001 | 0.002 | ˂0.001 | 0.039 |
[i] PM1, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) 1 mg kg−1;
[ii] PM2, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) 2 mg kg−1;
[iii] PM3, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) 3 mg kg−1;
[iv] SeNPs1, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.001 mg kg−1;
[v] SeNPs2, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.002 mg kg−1;
[vi] SeNPs3, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.003 mg kg−1.
Table 6.
Body chemical analysis of Nile tilapia fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) (1, 2 and 3 g kg−1) or selenium nanoparticles (SeNPs) (1, 2 and 3 mg kg−1) for 26 days and then exposed to sublethal dose of acrylamide (
96 h LC50 = 34.6 mg L−1) for 30 days
| MOT | DM | Ash | OM | EE | CP | |
|---|---|---|---|---|---|---|
| CTR | 4.10±0.11 c | 95.89±0.13 a | 16.48±0.17 | 83.51±1.27 | 26.51±0.23 a | 60.67±1.30 |
| PM1 | 5.12±0.81 a | 94.87±0.81 a | 20.49±0.81 | 79.50±1.81 | 19.45±1.89 c | 64.01±2.81 |
| PM2 | 5.16±0.24 c | 94.83±0.24 a | 18.77±0.69 | 81.22±1.69 | 22.89±0.89 abc | 61.97±1.36 |
| PM3 | 4.53±0.22 c | 95.46±0.22 a | 16.86±0.96 | 83.13±1.96 | 25.19±1.50 ab | 62.40±1.67 |
| SeNPs1 | 7.47±0.83 b | 92.53±1.03 b | 19.93±0.39 | 80.06±1.29 | 20.89±0.72 c | 62.50±0.58 |
| SeNPs2 | 5.43±0.21 c | 94.56±0.21 a | 17.28±0.53 | 82.71±1.54 | 23.05±0.64 abc | 57.68±5.69 |
| SeNPs3 | 3.76±0.29 c | 96.23±0.29 a | 18.64±1.16 | 81.35±1.16 | 25.99±1.50 a | 61.09±0.59 |
| P value | ||||||
| linear | 0.002 | 0.002 | 0.836 | 0.836 | 0.525 | 0.327 |
| quadratic | 0.003 | 0.003 | 0.441 | 0.441 | 0.007 | 0.456 |
| cubic | 0.029 | 0.029 | 0.140 | 0.140 | 0.426 | 0.232 |
[i] PM1, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) 1 mg kg−1;
[ii] PM2, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) 2 mg kg−1;
[iii] PM3, fish group fed diets supplemented with probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) 3 mg kg−1;
[iv] SeNPs1, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.001 mg kg−1;
[v] SeNPs2, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.002 mg kg−1;
[vi] SeNPs3, fish group fed diets supplemented with bacterial synthesized selenium nanoparticles 0.003 mg kg−1.

Figure 2.
Effects of enriched tilapia diets with several levels of probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) (1, 2 and 3 mg kg−1) or bacterial synthesized selenium nanoparticles (SeNPs) (1, 2 and 3 mg kg−1) for 26 days and then exposed to sublethal dose of acrylamide (
96 h LC50 = 34.6 mg L−1) for 30 days on total and lactic acid bacterial count and coliform counts of experimental feed. The oneway ANOVA analysis was applied to identify the significant differences (P<0.05) between treated and non-treated groups. NS indicated that there were no significant differences identified between tested groups

Figure 3.
Effects of enriched tilapia diets with several levels of probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) (1, 2 and 3 mg kg−1) or bacterial synthesized selenium nanoparticles (SeNPs) (1, 2 and 3 mg kg−1) for 26 days and then exposed to sublethal dose of acrylamide (
96 h LC50 = 34.6 mg L−1) for 30 days on total and lactic acid bacterial count and coliform counts (ND; not detected) of intestinal samples. The one-way ANOVA analysis was applied to identify the significant differences (P<0.05) between treated and non-treated groups

Figure 4.
Effects of enriched tilapia diets with several levels of probiotic mixture (Bacillus coagulans and Lactobacillus paraplantarum) (1, 2 and 3 mg kg−1) or bacterial synthesized selenium nanoparticles (SeNPs) (1, 2 and 3 mg kg−1) for 26 days and then exposed to sublethal dose of acrylamide (
96 h LC50 = 34.6 mg L−1) for 30 days on total and lactic acid bacterial count and coliform counts (ND; not detected) of fish rearing water samples. The one-way ANOVA analysis was applied to identify the significant differences (P<0.05) between treated and non-treated groups

Figure 5.
Representative photomicrograph of H&E stained sections from gills (scale bar 100 μm) showing: A (positive control group): destruction of most secondary gill lamellae (curved arrow), dilated capillaries within primary gill lamellae (arrowhead) and some secondary lamellae fused with inflammatory cells (arrow). B (CTR), C (PM1), E (PM3),G (SeNP2): normal morphological striations of primary filaments (arrowheads) and secondary filament (arrow) in CTR (control–ve), PM1, PM3, SeNP2, respectively. D (PM2): focal thickened area of both primary gill lamellae (arrowhead) and secondary gill lamellae (arrow) by inflammatory cells infiltrates in PM2 treated group. F (SeNp1): some capillaries engorged at secondary filaments (arrowhead) and aggregates of lymphocytes in a few secondary filaments (arrow) in SeNp1 treated group. H (SeNP3): invasionof some secondary gill lamellae by inflammatory cells (arrow) and apparent normal primary gill filaments (arrowhead) in SeNP3 treated group

Figure 6.
Representative photomicrograph of H&E-stained sections from hepatopancreas (scale bar 100 μm) showing: A: focal necrotic area of the pancreatic acini (arrowhead) with fatty cysts (arrow) and congestion of vasculatures (curved arrow) in control+ve group. B, C, E, G: normal architectures of hepatic cells (star), sinusoids, and hepatoportal pancreas (arrow) in CTR (control–ve), PM1, PM3, SeNP2, respectively. D: fatty change of pancreatic acini (arrow), congested hepatic blood vessels (arrowhead) and moderate areas of vacuolated hepatocytes (star) in PM2 treated group. F: peripancreatic fatty change (arrow), congested portal vein (arrowhead) and apparently normal most hepatic parenchyma (star) in SeNp1 treated group. H: Preserved structures of hepatic acini (star), pancreatic acini (arrow) and vascular tissue in in SeNP3 treated group

Figure 7.
Representative photomicrograph of H&E stained sections from spleen (scale bar 20 μm) showing: A: marked depleted areas of white pulp (star) with wide areas of melanomacrophages centers (arrowhead) in control+ve group. B, C, E, G: normal histological architectures of white pulps (arrow) with ellipsoids arterioles (curved arrows), few melanomacrophages centers (arrowhead) and red pulps (stars) in CTR (control–ve), PM1, PM3, SeNP2, respectively. D: high density of melanomacropahges centers (arrowhead), dilated splenic sinusoids (arrow) in PM2 treated group. F: widespread areas of melanomacropahges centers (arrowhead) and alternated white and red pulps (star) in SeNp1 treated group. H: moderate area of melanomacropahges centers within white pulp areas (arrowhead), dilated splenic vasculatures (arrow) and aggregations of different hemopiotic series within red pulp (star) in SeNP3 treated group
